Data on Fish-Oil Pill May Justify Amarin's Surging Stock Price

(Bloomberg) -- Amarin Corp.’s fish-oil pill improved survival for high-risk cardiovascular patients in a long-term study, further evidence that the company may have a blockbuster drug on its hands.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.